Cargando…
Assessing the importance of interleukin-6 in COVID-19
Autores principales: | Chen, Luke Y C, Hoiland, Ryan L, Stukas, Sophie, Wellington, Cheryl L, Sekhon, Mypinder S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836242/ https://www.ncbi.nlm.nih.gov/pubmed/33460569 http://dx.doi.org/10.1016/S2213-2600(20)30600-7 |
Ejemplares similares
-
Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome
por: Chen, Luke Y.C., et al.
Publicado: (2020) -
Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome
por: Chen, Luke Y.C., et al.
Publicado: (2021) -
Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality
por: Leatherdale, Alexander, et al.
Publicado: (2022) -
The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19
por: Hoiland, Ryan L., et al.
Publicado: (2020) -
Quantification of Neurological Blood-Based Biomarkers in Critically Ill Patients With Coronavirus Disease 2019
por: Cooper, Jennifer, et al.
Publicado: (2020)